There was also a lower 3-month mortality (31% vs 39%) for the antiplatelet-therapy group.
Antiplatelet therapy linked to less severe COVID outcomes
Published in COVID-19
More from COVID-19More posts in COVID-19 »
November 27, 2024
The International Organization for the Proctection Against COVID-19
There was also a lower 3-month mortality (31% vs 39%) for the antiplatelet-therapy group.
Published in COVID-19